赖浩强

职称:博士 电话:
单位:化学与材料学院 邮箱: 962762520@qq.com

研究方向:肿瘤靶向性纳米创新药物

教育背景


09/2017–至今, 在读博士生物医药专业,暨南大学细胞生物学系

09/2011–06/2014, 硕士(生物化学与分子生物学),暨南大学

09/2011-06/2007, 学士(生物制药),广东药科大学



发表论文


1.Haoqiang Lai, Xiaoyan Fu, Chengcheng Sang, Liyuan Hou, Pengju Feng, Xiaoling Li,* and Tianfeng Chen*.Selenadiazole Derivatives Inhibit Angiogenesis-Mediated Human Breast Tumor Growth by Suppressing the VEGFR2-Mediated ERK and AKT Signaling Pathways. Chemistry-An Asian Journal.Chem. Asian J. 2018, 13, 1447 – 1457. (Co-first author)

2. Haoqiang Lai, Xiang Zhang, Lina Xie, Jinjin Chen, Tianfeng Chen*. Enhancement of Antiangiogenic Efficacy of Iron(II) complex by Selenium Substitution. Chemistry-An Asian Journal, 2017, Chem. Asian J. 2017, 12, 982 – 987. (Cover)

3. Lai Haoqiang‡, Zhao Z‡, Li L, Zheng W and Chen T* Antiangiogenic ruthenium(II) benzimidazole complexes, structure-based activation of distinct signaling pathways. Metallomics, 2015, 7(3), 439-447. (Co-first author, Front Cover)

4.Su J1*#, Lai Haoqiang#, Chen1 J, Li L1, Wong YS, Chen T, Li X* Natural Borneol, a monoterpenoid compound, potentiates selenocystine induced apoptosis in human hepatocellular carcinoma cells by enhance-ment of cellular uptake and activation of ROS-mediated DNA damage. PloS one 2013,20;8(5):e63502. (Co-first author)

5.Lizhen He, Haoqiang Lai, Tianfeng Chen. Dual-function nanosystem for synergetic cancer chemo-/radiotherapy through ROS-mediated signaling pathways. Biomaterials.2015, 51,30-42.

6.Qiang xie, Lizhen He; Haoqiang Lai, Wenjie Zheng, Tianfeng Chen. Selenium substitution endows cystine with radiosensitization activity against cervical cancer cells. Biochemical and Biophysical Research Communications. 2014, 4, 34210-34216.

7. Qiang Xie, Lizhen He, Haoqiang Lai, Wenjie Zheng, Tianfeng Chen*. Selenium substitution endows cystine the radiosensitization activity against cervical cancer cells. RSC Advances, 2014, 4 (64), 34210 - 34216.

8. Lizhen He, Shengbin Ji, Haoqiang Lai and Tianfeng Chen*. Selenadiazole Derivatives as Theranostic Agents for Simultaneous Cancer Chemo-/Radiotherapy by Targeting Thioredoxin Reductase. J. Mater. Chem. B, 2015, 3, 8383 – 8393.

9. 赖浩强,袁日明,贺利贞,陈填烽.冰片及其纳米化制剂的生物医药应用进展. 药学进展,2019,43 (5):334-342.


专利发明


  1. 陈填烽,赖浩强. 右旋龙脑作为阿霉素增敏剂在制备抗肺癌药物中的应用,201811204466.8



获奖情况


2013/12/31研究生国家奖学金